| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.01 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |